Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pixantrone and Rituximab in Relapsed or Refractory Indolent NHL
NCT00060671Phase 3Terminated
- Sponsor
- CTI BioPharma Corp.
- Start
- Jan 2005
- Primary completion
- Jan 2006
- Countries
- 1
01
Overview
A Phase 3 trial of pixantrone in Non-Hodgkin lymphoma (NHL), sponsored by CTI BioPharma Corp.. Started Jan 2005; status: terminated.
02
Drugs
pixantrone
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00060671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060671.